Cargando…

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

BACKGROUND: The roles and clinical values of synaptojanin 2 (SYNJ2) in lung squamous cell carcinoma (LUSC) remain unclear. METHODS: A total of 2824 samples from multi-center were collected to identify the expression of SYNJ2 in LUSC by using Wilcoxon rank-sum test, t-test, and standardized mean diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Wei, Li, Guo-Sheng, Gao, Li, Lu, Hui-Ping, Zhou, Hua-Fu, Kong, Jin-Liang, Chen, Gang, Xia, Shuang, Wei, Hong-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112447/ https://www.ncbi.nlm.nih.gov/pubmed/35581615 http://dx.doi.org/10.1186/s12920-022-01266-0

Ejemplares similares

Electroclinical Findings of SYNJ1 Epileptic Encephalopathy
por: Samanta, Debopam, et al.
Publicado: (2020)

Temporal Vestibular Deficits in synaptojanin 1 (synj1) Mutants
por: Gao, Yan, et al.
Publicado: (2021)

Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism
por: Lesage, Suzanne, et al.
Publicado: (2021)

The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation
por: Gao, Li, et al.
Publicado: (2019)

SYNJ1 gene associated with neonatal onset of neurodegenerative disorder and intractable seizure
por: Al Zaabi, Nuha, et al.
Publicado: (2017)

Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer
por: Tang, Deng, et al.
Publicado: (2022)

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations
por: Fasano, Dominga, et al.
Publicado: (2018)

Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1
por: Jacquemyn, Julie, et al.
Publicado: (2023)

Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers
por: Li, Guo-Sheng, et al.
Publicado: (2022)

A novel SYNJ1 homozygous variant causing developmental and epileptic encephalopathy in an Afro‐Caribbean individual
por: Maj, Mary, et al.
Publicado: (2022)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

Pan-cancer analysis of LINC02535 as a potential biomarker and its oncogenic role in lung adenocarcinoma
por: Dai, Shuang, et al.
Publicado: (2022)

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma
por: Liu, Xiao, et al.
Publicado: (2016)

Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression
por: De Rosa, Laura, et al.
Publicado: (2022)

The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
por: Tang, Yu-Lu, et al.
Publicado: (2022)

RAB5C, SYNJ1, and RNF19B promote male ankylosing spondylitis by regulating immune cell infiltration
por: Zhang, Di, et al.
Publicado: (2021)

A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
por: Liu, Wei, et al.
Publicado: (2019)

CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis
por: Wang, Libo, et al.
Publicado: (2021)

A 28 nt long synthetic 5(′)UTR (synJ) as an enhancer of transgene expression in dicotyledonous plants
por: Kanoria, Shaveta, et al.
Publicado: (2012)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

MicroRNA expression profiling after recurrent febrile seizures in rat and emerging role of miR-148a-3p/SYNJ1 axis
por: Xu, Jian, et al.
Publicado: (2021)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Establishing a prognostic model for metachronous second squamous cell lung cancer in patients with resected squamous cell lung cancer
por: Fu, Shen-Shen, et al.
Publicado: (2022)

Prognostic and immune infiltrative biomarkers of CENPO in pan–cancer and its relationship with lung adenocarcinoma cell proliferation and metastasis
por: Wang, Yuanbiao, et al.
Publicado: (2023)

RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer
por: Liao, Cui, et al.
Publicado: (2022)

The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria
por: Hartmann, Christian, et al.
Publicado: (2020)

Expression of Synj2bp in mouse liver regulates the extent of wrappER-mitochondria contact to maintain hepatic lipid homeostasis
por: Ilacqua, Nicolò, et al.
Publicado: (2022)

A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target
por: Li, Han, et al.
Publicado: (2023)

Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening
por: Yan, Tao, et al.
Publicado: (2021)

FAM65A as a novel prognostic biomarker in human tumors reveal by a pan-cancer analysis
por: Liang, Wenken, et al.
Publicado: (2021)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
por: He, Ya, et al.
Publicado: (2022)

Analysis of differentially expressed genes discovers Latroeggtoxin VI-induced changes and SYNJ1 as a main target in PC12 cells
por: Yu, Dianmei, et al.
Publicado: (2023)

Pan-cancer characterization of ncRNA synergistic competition uncovers potential carcinogenic biomarkers
por: Zhang, Junpeng, et al.
Publicado: (2023)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling
por: Wang, Miao, et al.
Publicado: (2017)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Pan-Cancer Identification of Prognostic-Associated Metabolic Pathways
por: Chen, Wenbo, et al.
Publicado: (2023)

Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Li, Yongsheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpn2cv1kdhfgsmcr970f1ftldb